Omega-3 fatty acids may help improve treatment and quality of life in cancer patients

Adding omega-3 fatty acids to anti-tumor medications may improve treatment response and quality of life for cancer patients according to a new study by researchers at the University Hospitals of Leicester in the United Kingdom.

The study, published today in the OnlineFirst version of the Journal of Parenteral and Enteral Nutrition (JPEN), the research journal of the American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.), examined 50 patients with advanced pancreatic cancer.

Patients were given 1,000 mg of gemcitabine weekly followed by up to 100 g of omega-3 rich lipid emulsion for three weeks followed by a rest week. This was continued for up to six cycles, progression, unacceptable toxicity, patient request, or death.

The study found evidence of activity in response and disease stabilization rates, reduction in liver metastasis volume, and improved quality of life scores in this group of patients.

While this is the first study to use with a chemotherapy agent in a cancer setting, the researchers believe the results are encouraging enough to warrant further investigation in a randomized phase III trial.


Explore further

Benefits of combo lipid emulsion no greater than soy-based emulsion for pediatric patients

Provided by American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.)
Citation: Omega-3 fatty acids may help improve treatment and quality of life in cancer patients (2015, July 28) retrieved 4 August 2020 from https://medicalxpress.com/news/2015-07-omega-fatty-acids-treatment-quality.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
149 shares

Feedback to editors

User comments